etidronate has been researched along with Basedow Disease in 2 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Majima, T | 1 |
| Komatsu, Y | 1 |
| Doi, K | 1 |
| Takagi, C | 1 |
| Shigemoto, M | 1 |
| Fukao, A | 1 |
| Morimoto, T | 1 |
| Corners, J | 1 |
| Nakao, K | 1 |
| Bisschop, PH | 1 |
| Adam, JA | 1 |
| Wiersinga, WM | 1 |
1 trial available for etidronate and Basedow Disease
| Article | Year |
|---|---|
Clinical significance of risedronate for osteoporosis in the initial treatment of male patients with Graves' disease.
Topics: Adult; Alkaline Phosphatase; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Di | 2006 |
1 other study available for etidronate and Basedow Disease
| Article | Year |
|---|---|
Increased uptake of technetium-99m HDP in the subcortical area of both femurs in a patient with Graves' disease.
Topics: Etidronic Acid; Female; Femur; Graves Disease; Humans; Middle Aged; Organotechnetium Compounds; Radi | 2007 |